To investigate the effects of fellowship training on a surgeon's learning curve for cancer control after open radical prostatectomy.
10%), but the difference between the groups' subsequent learning curves was not significant (P ϭ .9 for interaction).
Conclusions
The learning curve for biochemical recurrence depends on surgical training, whereas the learning curve for surgical margins does not. This difference suggests that improvements in margin rates result from reflection on specific aspects of surgical procedure, whereas improvements in biochemical recurrence occur by some general process of improvement in surgical technique. Further research into the mechanisms of surgical learning is warranted. Acad Med. 2010; 85:863-868.
Weandothermembersofourgroup 1 previously reported that a surgeon's rates of cancer control after radical prostatectomy improve with increasing experience: This process is called the "surgical learning curve." The primary analysis found that a typical patient had a 17.9% risk of recurrence by five years if treated by an inexperienced surgeon with only 10 prior cases, but a 10.7% risk if treated by a more experienced surgeon with 250 prior cases. 1 We and other members of our group 2 subsequently reported the learning curve separately by pathologic stage. In patients with organ-confined disease, the most common presentation in contemporary practice, recurrence rates were approximately 10 times as high for patients treated by the least experienced surgeons as for similar patients treated by the most experienced surgeons. 2 We continue to analyze our data to identify other modifiers of the learning curve. One obvious potential modifier is a surgeon's education: It is plausible that the way in which surgeons are trained before they treat their first case as an attending surgeon will affect how they continue to learn during their careers. Differences in surgical training likely are subtle, are poorly documented, and thus are difficult to study. The exception is fellowship training, which is a clearly documented and relatively unequivocal marker of a distinct difference in surgical training.
In this study, we aimed to address three hypotheses concerning the effects of fellowship training on the learning curve. First, we hypothesized that overall rates of biochemical recurrence would differ between surgeons with and without fellowship training. Second, we hypothesized that this difference would result from two separate effects: Fellowship-trained surgeons would, as a result of their fellowship training, have initial results that were better than the results of surgeons without fellowship training. Third, we hypothesized that fellowship-trained surgeons would have improvements in outcome with increasing experience that were more rapid than those of their non-fellowshiptrained counterparts-that is, the fellowship-trained surgeons would have a shorter learning curve. We also sought to repeat our analyses by using positive surgical margins as an end point, in the hope that any differences in learning curve would be informative of the mechanisms of surgical learning.
Method

Sources of data and study cohort
The study cohort was described previously. 1 In brief, the data set consisted of 7,765 patients with clinically localized prostate cancer that was treated with open radical retropubic prostatectomy between 1987 and 2003 at one of four institutions (Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, Wayne State University, or the Cleveland Clinic). Patients receiving neoadjuvant or adjuvant therapy were excluded. All data were deidentified before analysis, and the study received appropriate institutional review board approvals from each institution.
Outcomes
The surgeons conducted patient followup according to accepted clinical practice at each of the four institutions. In general, follow-up consisted of measurement of serum prostate-specific antigen (PSA) levels every three to four months during the first postoperative year, semiannually the second postoperative year, and annually thereafter. Cancer recurrence was defined as a corroborated rising PSA level Ͼ0.4 ng/mL; in rare cases (Ͻ1% of cases at Memorial Sloan-Kettering Cancer Center), secondary treatment was initiated for a detectable rising PSA level Յ0.4 ng/mL: such treatment was counted as an event. Surgical margin status was defined as the presence or absence of tumor cells at the inked margin of resection in the prostatectomy specimen.
Explanatory variables
We asked all surgeons to describe any fellowship training and to indicate whether their current practice was academic. We defined fellowship training as at least one year of studies after residency. We categorized surgeons as having an academic appointment if they were faculty members of the department of urology at their respective institutions.
Statistical methods
For each patient, we coded the surgeon's experience as the number of radical prostatectomies conducted by the surgeon before that patient's operation. This number reflects total prior experience, including operations conducted at former institutions and those conducted in patients who were ineligible for this analysis. Only a single billing surgeon was recorded for each operation: Operations at which a surgeon assisted, such as those conducted during fellowship training, were not counted as prior experience.
Because length of follow-up is not independent of surgeon experience, we used a log-logistic survival distribution to model hazard over time in all analyses. We also adjusted for within-surgeon clustering using the robust estimator of variance by specifying the cluster option in Stata software (version 9.2; StataCorp, College Station, Texas). We did not cluster by institution, because each of these surgeons practiced at a single institution throughout the time frame of the study, and, therefore, the institution could not affect a surgeon's learning curve.
The study hypotheses
Our first hypothesis, briefly described in the introduction, can also be stated as follows: A patient has a lower risk of recurrence if treated by a surgeon with fellowship training than if treated by a non-fellowship-trained surgeon. To test this hypothesis, we entered fellowship training (yes/no) in a model, and we adjusted for case mix and the year of the surgery. The variables we used to adjust for case mix were preoperative PSA level, pathologic stage (i.e., extracapsular extension, seminal vesicle invasion, or lymph node invasion), and the Gleason score of the pathology specimen.
Our second hypothesis can also be stated as follows: The risk of recurrence for the first patient treated by a fellowshiptrained surgeon is lower than that for the first patient treated by a non-fellowshiptrained surgeon. To test this hypothesis, we fitted a model including surgeon experience and fellowship training, and we adjusted for case mix and the year of the surgery. From the model, we estimated the five-year probability of recurrence for a surgeon's first case. We used bootstrap methods with 1,000 replications to estimate the 95% confidence interval (CI) and P value for the difference in this probability between fellowship-and non-fellowship-trained surgeons.
Our third hypothesis was that fellowshiptrained surgeons learn at a faster rate than do non-fellowship-trained surgeons. To test this hypothesis, we performed an interaction analysis; an interaction between two variables exists if the effect of one variable depends on the level of the other. If the interaction term between fellowship training and surgeon experience is statistically significant, then the effect of surgeon experience on recurrence-that is, the "learning curve"-is modified by whether a surgeon underwent fellowship training. The sign of the interaction term indicates whether learning was faster or slower for fellowship-trained surgeons. We conducted the interaction analysis with adjustment for case mix and year of the surgery. We restricted this analysis to the 3,415 patients treated by a surgeon with no more than 216 previous surgeries, because the most experienced surgeon among those without fellowship training had a lifetime experience of 217 surgeries.
We entered surgeon experience as a continuous variable in all models by using restricted cubic splines to model its nonlinear relationship with outcome. Because the distribution of surgeon experience varied among fellowship-and non-fellowship-trained surgeons, we varied the position of knots for the cubic splines according to the analysis performed. For our second hypothesis, knots were placed at the quartiles. For our third hypothesis, in which the range for surgical experience was limited, we placed a single knot at 100 prior surgeries.
To plot the learning curve for biochemical recurrence, we fitted a model including surgeon experience (with adjustment for case mix and year of surgery) separately for fellowship-and non-fellowship-trained surgeons. We then predicted the five-year recurrencefree probability at the mean level of covariates for the entire cohort of 7,765 patients. We repeated all analyses for the outcome of positive surgical margins, by using logistic regression in place of survival models.
Results
We evaluated 72 surgeons in this study ( Table 1 ). Most (53; 74%) of the surgeons did not have fellowship training. We found a strong association between training and surgeon experience: Fellowship-trained surgeons performed a median of 296 total cases, but nonfellowship-trained surgeons performed 32. In this series of 7,765 patients, 82% were treated by fellowship-trained surgeons. Only two non-fellowship-trained surgeons performed Ͼ100 total cases (120 and 217 cases, respectively). In contrast, six fellowship-trained surgeons performed Ͼ500 total cases (535, 614, 710, 874, 1,337, and 1,979 cases, respectively). Table 2 shows the baseline characteristics of the cohort. As compared with patients treated by fellowship-trained surgeons, those treated by non-fellowship-trained surgeons were slightly but significantly older (P Ͻ .001) and had slightly but significantly higher Gleason scores (62% versus 49% had a Gleason score of Ն7; P Ͻ .001) but slightly but significantly lower rates of locally advanced disease 31% versus 34%, P ϭ .045. Among all 7,765 patients, there were 1,256 recurrences. Median follow-up for patients without recurrence was 3.9 years. Our first hypothesis focused on whether, overall, fellowship training affects recurrence: We found that, with adjustment for case mix and the year of the surgery, fellowship training was significantly associated with recurrence (P ϭ .001). The estimated five-year probability of recurrence for a patient with typical cancer characteristics who was treated by a fellowship-or nonfellowship-trained surgeon was, respectively, 11.3% or 16.0% (difference: 4.7%; 95% CI: 2.6%, 7.4%). There was no significant difference in recurrence between the patients of fellowship-and non-fellowship-trained surgeons if the surgeon's experience was included in the model (P ϭ .9); this finding suggested that fellowship-trained surgeons do better on average because they are more experienced.
The learning curve for biochemical recurrence, stratified by the training of the operating surgeon, is shown in Figure  1 . The estimates given are for a case with tumor characteristics that are typical for the sample as a whole; that is, we used mean values of covariates in the model. The results for fellowship-and nonfellowship-trained surgeons are initially similar, but they improve steadily only for the former group. It appears that the results for non-fellowship-trained surgeons deteriorate after the first few cases, but the change is very small and well within the 95% CIs, and so the learning curve should be seen as essentially flat. A single non-fellowshiptrained surgeon performed Ͼ120 cases: Rates of cancer control for this surgeon were comparable to those for the fellowship-trained surgeons. This nonfellowship-trained surgeon trained many years ago, before the current system of fellowship training was well established.
To test formally whether initial results vary by fellowship training, we calculated estimates for the probability of recurrence for a surgeon's first case. The five-year probability of recurrence for a surgeon's first case was 19.4% and 18.3% for fellowship-and non-fellowshiptrained surgeons, respectively (difference: Ϫ1.1%; 95% CI: Ϫ5.5%, 3.0%; P ϭ .7).
The interaction analysis for our third hypothesis, comparing rates of learning, included a subgroup of 3,415 patients.
There were 738 recurrences in this subgroup, and median follow-up for patients without recurrence was 4.3 years. In a model including the patients of both fellowship-and non-fellowship-trained surgeons, the interaction term between fellowship training and surgeon experience was statistically significant (P ϭ .006), and associated with lower recurrence rates, which confirmed that fellowship-trained surgeons learn faster than do non-fellowship-trained surgeons.
The outlying surgeon in our analysis, a non-fellowship-trained surgeon who had approximately twice the lifetime experience of the next-most-experienced non-fellowship-trained surgeon, and whose cancer control rates were comparable to those of the fellowshiptrained surgeons, had an academic appointment. This fact raises the possibility that it is academic practicerather than fellowship training-that is causally associated with the learning curve. This possibility is supported by the strong concordance between fellowship training and an academic position: All of the 19 fellowship-trained surgeons in this study practiced in an academic setting, whereas only 11 (21%) of the 53 nonfellowship-trained surgeons did so. Moreover, we found that, when we repeated our analyses by using the predictor of academic or nonacademic practice in place of the predictor of fellowship or nonfellowship trainingand did not control for fellowship training-academic practice was associated with a significantly lower risk of recurrence than was nonacademic practice (P ϭ .005; absolute risk difference at five years: 4.6%; 95% CI: 2.1%, 7.6%). However, in the interaction analysis, the difference between the learning curves for academic and nonacademic surgeons was not statistically significant (P ϭ .11).
To explore further the relationship between fellowship training and academic practice, we repeated the interaction analysis for fellowship training and surgeon experience while restricting the sample to the 30 academic surgeons. The results did not differ substantially from our original analysis: The interaction term between fellowship training and surgeon experience was statistically significant (P ϭ .03) and protective of recurrence. This finding 
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Academic Medicine, Vol. 85, No. 5 / May 2010 appears to confirm both that the key explanatory variable is fellowship training and that practicing in an academic environment does not, in itself, confer the ability to improve with increasing experience. Figure 2 shows the learning curve for surgical margins, separately for surgeons with and without fellowship training. In contrast to the relation of recurrence rates for fellowship-and non-fellowshiptrained surgeons, fellowship-trained surgeons start with significantly better margin rates (35.9%) than do nonfellowship-trained surgeons (41.5%) (absolute difference: 5.6%; 95% CI: 1.1%, 9.5%; P ϭ .005), but there are no significant differences between the groups in the subsequent learning curve (P ϭ .9 for interaction term).
Discussion
Our group's earlier publication 1 reported a learning curve for biochemical recurrence after radical prostatectomy, with cancer control improving as surgeons accrue surgical experience. Here, we provide evidence that this learning curve is found only in surgeons who have undergone fellowship training and that the recurrence learning curve for surgeons without fellowship training is essentially flat. We also found that few of the surgeons without fellowship training ever developed a significant lifetime case load. Consequently, overall cancer control outcomes were superior for fellowship-trained surgeons.
We made three additional observations that we believe are particularly informative about surgical learning. First, we found that recurrence rates for the first patient treated by a surgeon There is a clear and obvious difference between the ways in which a surgeon receives feedback with respect to margins and to recurrence. A surgeon is told of the patient's margin status relatively soon after surgery and may be able to relate a positive margin to a particular aspect of the procedure. In contrast, biochemical recurrences occur many years after surgery, and the surgeon is unlikely to remember any specifics about the patient's surgery.
Accordingly, we draw the tentative conclusion that improvements in margin rates result from reflection on specific aspects of the surgical procedure, whereas improvements in biochemical recurrence occur by a general process of improving the surgical technique. Why only fellowship-trained surgeons experience . . can eliminate the learning curve for laparoscopic bypass"-was drawn by Ali and colleagues 4 from their study on bariatric surgery. Although that study included more surgeons (5 rather than 1) and more patients (500 rather than 32) than did the study by Brown and Sajadi, it did not include a comparison group of surgeons without fellowship training. Oliak and colleagues 5 did include in their study a comparison group of sorts, by reporting the results of two surgeons, one with and one without fellowship training. But we deem questionable their conclusion that "fellowship training improves perioperative outcomes during a surgeon's early experience," 5 on the grounds that a comparison of just two surgeons may provide information only about which of the two has better outcomes. In another study of radical prostatectomy, Rosser and colleagues 6 similarly concluded that fellowship training was of benefit by examining the results of two surgeons who treated a total of 66 patients.
In contrast, our study included a large number of surgeons (72) and patients (7,765), directly compared the results of surgeons with and without fellowship training, and used as an outcome the very reason that patients presented to the surgeon: cure of prostate cancer. We also avoided what we saw as a trivializing assumptionthat the learning curve can be precluded-which suggests that a surgeon's results would never improve between the first procedure as attending surgeon and the final Figure 2 The learning curve for positive surgical margins, shown separately for surgeons with and without fellowship training, with 95% CIs. Predicted probability of a positive surgical margin, calculated from a statistical model, is plotted against the surgeon's experience. Probabilities are for a patient with typical cancer severity in the entire cohort of 7,765 (mean prostate-specific antigen levels, pathologic stage, and pathologic grade). Black lines: fellowship-trained; gray lines: non-fellowshiptrained; dashed gray line, the single nonfellowship-trained surgeon with Ͼ120 surgeries. The 95% CIs are shown by thin black and gray lines.
Figure 1
The learning curve for cancer control after radical prostatectomy, shown separately for surgeons with and without fellowship training, with 95% CIs. Predicted probability of freedom from biochemical recurrence (BCR) at five years, calculated from a statistical model, is plotted against the surgeon's experience. Probabilities are for a patient with typical cancer severity in the entire cohort of 7,765 (mean prostate-specific antigen levels, pathologic stage, and pathologic grade). Black lines: fellowship-trained; gray lines: non-fellowshiptrained; dashed gray line, the single nonfellowship-trained surgeon with Ͼ120 surgeries. The 95% CIs are shown by thin black and gray lines.
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procedure of a long career. In our view, surgical learning curves can be of different shapes and sizes, but none should be flat.
Conclusions
In sum, we found a learning curve for cancer control after radical prostatectomy only for fellowship-trained surgeons. Accordingly, we could conclude either that fellowship training confers the ability to improve surgical technique or that surgeons who chose a fellowship are those with a greater a propensity to reflect on and improve their technique. Given the very large differences in outcome between patients treated at different points on the surgical learning curve, there is a clear warrant for further research into the mechanisms of surgical learning, especially when it occurs in the absence of feedback as to outcome.
